MedPath

Effects of Tea Catechin Consumption on the Prophylaxis of Influenza Infection

Not Applicable
Completed
Conditions
Influenza Infection
Interventions
Dietary Supplement: tea catechin extracts
Registration Number
NCT01008020
Lead Sponsor
Masahiro Morikawa
Brief Summary

The Purpose of this study is to evaluate the effects of 5 months catechin consumption on the prevention of influenza infection.

Detailed Description

Catechins are the major components of tea flavonoids and are reported to possess physiological activities such as antiviral effects. Recent experimental studies have revealed that tea catechin extracts prevent influenza infection, but few studies have been conducted on the clinical effects of tea catechin consumption on the prophylaxis of influenza infection. Based on these backgrounds, we designed a prospective randomized controlled study to evaluate the effects of 5 months tea catechin consumption on the prophylaxis of influenza infection.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • aged over 20 years
  • possible to maintain without drinking tea more than 250 ml per day during the study
  • possible to maintain without taking supplements or herbal products including catechin extracts during the study
  • possible to fill out a questionnaire personally
  • Obtained written informed consent before participation
Exclusion Criteria
  • Possessing some chronic infectious diseases in need of therapy
  • Possessing tea or catechin allergy
  • Possessing a history of influenza infection before six months prior to the study
  • diagnosed as inadequate for other reasons to participate the study by principal investigator

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Tea catechin extractstea catechin extracts-
Primary Outcome Measures
NameTimeMethod
the incidence rates of influenza infectionUntil 5 months consumption of the study capsules
Secondary Outcome Measures
NameTimeMethod
the incidence rates of upper respiratory tract infectionsUntil 5 months consumption of the study capsules
the severity of the symptoms and the duration of the cold among incident casesUntil 5 months consumption of the study capsules
occurrence of the adverse eventsUntil 5 months consumption of the study capsules

Trial Locations

Locations (1)

White Cross Nursing Home

🇯🇵

Higashi Murayama, Tokyo, Japan

© Copyright 2025. All Rights Reserved by MedPath